How Ind AS impacts pharma businesses?
Sumit Seth, Partner, Price Waterhouse & Co explains how the introduction of the new accounting standards will impact the…
Author
How to effectively address the issue of unaffordable drug pricing in India?
Abhishek Thakur in this article tells us about how to improve overall affordability of healthcare in India
Seasonal influenza vaccines market will hit $4.3 bn by 2025
The market will grow at a compound annual growth rate of 3.3 per cent
Gastrointestinal drugs market to hit $48.4 bn dollars by 2022
Approval of new drugs, as well as rising prevalence, are expected to drive considerable growth
Major depressive disorder market will reach $5.8 bn by 2025 as awareness and drugs improve
The market will be primarily driven by the growth of atypical antipsychotics, along with the increasing global diagnosed…
Raising Standards
After a few falls starts and delays, India's pharmacopeia is finally being updated and harmonised with global norms. By Sachin…
CPhI & P-MEC India to be held in Mumbai
UBM India set to celebrate 10 years of success with one week of glory
CubeX to host conference on consumer healthcare in Mumbai
It would cover diverse topics such as building mega brands to penetrating unchartered territories, creating multiple touch points…
68th IPCE to be held in Hyderabad
Delegates from across the world will congregate in Visakhapatnam from December 16 to 18, 2016
Pharmasafe India successfully concludes its second edition
The conference brought together 102 attendees along with 25 eminent speakers to focus on the strategies and identify solutions to…